Polypyridyl ruthenium complexes : novel DNA-intercalating agents against human breast tumor.

Simple item page
dc.contributor.authorReis, João Paulo Barolli
dc.contributor.authorCorrea, Rodrigo de Souza
dc.contributor.authorMiranda, Fabio da Silva
dc.contributor.authorRibeiro, Juliana Uema
dc.contributor.authorBloch Junior, Carlos
dc.contributor.authorEllena, Javier Alcides
dc.contributor.authorMoreno, Virtudes
dc.contributor.authorCominetti, Márcia Regina
dc.contributor.authorBatista, Alzir Azevedo
dc.date.accessioned2018-10-15T16:09:55Z
dc.date.available2018-10-15T16:09:55Z
dc.date.issued2017
dc.description.abstractThis paper describes a new series of four DNA-intercalating agents with promising anticancer activities, based on ruthenium(II) with the planar ligand dpqQX (dpqQX = dipyrido[3,2-a:2',3'-c]quinoxaline[2,3-b]quinoxaline). The complexes identified as trans-[RuCl2(dppb)(dpqQX)], cis-[RuCl2(dppb)(dpqQX)], ct-[RuCl(CO)(dppb)(dpqQX)]PF6 and ct-[RuCl2(PPh3)2(dpqQX)] (dppb = 1,4-bis(diphenylphosphine)butane and PPh3 = triphenylphosphine) were characterized by 31P{1H} nuclear magnetic resonance (NMR) and infrared spectroscopies, cyclic voltammetry, molar conductance measurements, elemental analysis, mass spectrometry and X-ray diffraction analysis for complex ct-[RuCl2(PPh3)2(dpqQX)]. Their in vitro cytotoxic activities against MDA-MB-213 and MCF-7 breast cancer cells were evaluated and compared with normal L-929 cells. Low drug concentration at which 50% of the cells are viable relative to the control (IC50) values were obtained for all four complexes compared with a reference metallodrug, cisplatin. In addition, DNA affinity studies from titrations, as well as the images obtained by atomic force microscopy (AFM) involving pBR322 plasmid DNA, suggest interactions between the metal complexes and the DNA macromolecule, in which they act as intercalating agents. The intercalation of the complexes with DNA was confirmed by viscosity measurements.pt_BR
dc.identifier.citationREIS, J. P. B. et al. Polypyridyl ruthenium complexes : novel DNA-intercalating agents against human breast tumor. Journal of the Brazilian Chemical Society, São Paulo, v. 28, n. 10, p. 1879-1889, out. 2017. Disponível em: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017001001879>. Acesso em: 05 abr. 2018.pt_BR
dc.identifier.issn16784790
dc.identifier.urihttp://www.repositorio.ufop.br/handle/123456789/10368
dc.language.isoen_USpt_BR
dc.rightsabertopt_BR
dc.rights.licenseTodo o conteúdo do periódico Journal of the Brazilian Chemical Society, exceto onde identificado, está licenciado sob uma licença Creative Commons 4.0 que permite copiar, distribuir e transmitir o trabalho em qualquer suporte ou formato desde que sejam citados o autor e o licenciante. Fonte: Journal of the Brazilian Chemical Society <http://www.scielo.br/scielo.php?script=sci_serial&pid=0103-5053&lng=en&nrm=iso>. Acesso em: 02 jan. 2017.pt_BR
dc.subjectMetallo-intercalatorpt_BR
dc.subjectTumor cellspt_BR
dc.subjectDNA interactionpt_BR
dc.subjectCytotoxicitypt_BR
dc.titlePolypyridyl ruthenium complexes : novel DNA-intercalating agents against human breast tumor.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ARTIGO_PolypyridylRutheniumComplexes.pdf
Size:
2.16 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
924 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
DEQUI - Artigos publicados em periódicos